Wing Maria R, Ziegler Julie, Langefeld Carl D, Ng Maggie C Y, Haffner Steven M, Norris Jill M, Goodarzi Mark O, Bowden Donald W
Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Hum Genet. 2009 Jun;125(5-6):615-26. doi: 10.1007/s00439-009-0656-3. Epub 2009 Mar 26.
Multiple studies have identified FTO gene variants associated with measures of adiposity in European-derived populations. The objective of the study was to determine whether FTO variants were associated with adiposity, including visceral and subcutaneous adipose tissue (VAT, SAT), and glucose homeostasis measures in the Insulin Resistance Atherosclerosis Family Study (IRASFS). A total of 27 SNPs in FTO intron 1, including SNPs prominent in the literature (rs9939609, rs8050136, rs1121980, rs17817449, rs1421085, and rs3751812), were genotyped in 1,424 Hispanic Americans and 604 African Americans. Multiple SNPs were associated with BMI and SAT (P values ranging from 0.001 to 0.033), and trending or associated with waist circumference (P values ranging from 0.008 to 0.099) in the Hispanic Americans. No association was observed with VAT, illustrating that FTO variants are associated with overall fat mass instead of specific fat depots. For the glucose homeostasis measures, variants were associated with fasting insulin but, consistent with other studies, after BMI adjustment, no evidence of association remained. The lack of association of FTO SNPs with insulin sensitivity is consistent with the lack of association with VAT, since these traits are strongly correlated. In the African Americans, only rs8050136 and rs9939609 were associated with BMI and WAIST (P values of 0.011 and 0.034), and associated or trending towards association with SAT (P values of 0.038 and 0.058). These results confirm that FTO variants are associated with adiposity measures, predisposing individuals to obesity by increasing overall fat mass in Hispanic Americans and to a lesser degree in African Americans.
多项研究已在欧洲裔人群中确定了与肥胖指标相关的FTO基因变异。本研究的目的是确定FTO变异是否与肥胖相关,包括内脏和皮下脂肪组织(VAT、SAT),以及胰岛素抵抗动脉粥样硬化家族研究(IRASFS)中的葡萄糖稳态指标。对FTO内含子1中的27个单核苷酸多态性(SNP)进行了基因分型,其中包括文献中显著的SNP(rs9939609、rs8050136、rs1121980、rs17817449、rs1421085和rs3751812),涉及1424名西班牙裔美国人和604名非裔美国人。在西班牙裔美国人中,多个SNP与体重指数(BMI)和SAT相关(P值范围为0.001至0.033),并与腰围呈趋势性相关或相关(P值范围为0.008至0.099)。未观察到与VAT相关,这表明FTO变异与总体脂肪量相关,而非特定的脂肪储存部位。对于葡萄糖稳态指标,变异与空腹胰岛素相关,但与其他研究一致,在调整BMI后未发现关联证据。FTO SNP与胰岛素敏感性缺乏关联与与VAT缺乏关联一致,因为这些特征密切相关。在非裔美国人中,只有rs805了和rs9939609与BMI和腰围相关(P值分别为0.011和0.034),并与SAT相关或呈关联趋势(P值分别为0.038和0.058)。这些结果证实,FTO变异与肥胖指标相关,通过增加西班牙裔美国人的总体脂肪量使个体易患肥胖症,在非裔美国人中程度较轻。